*  Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients...
Drug Information available for: Cytarabine Daunorubicin Daunorubicin hydrochloride Idarubicin hydrochloride Idarubicin ... INDUCTION/RE-INDUCTION: Patients receive high dose cytarabine IV continuously on days 1-4 and idarubicin IV over 15 minutes on ... CONSOLIDATION: Patients receive vorinostat PO TID on days 1-3, cytarabine IV continuously on days 4-6, and idarubicin IV over ... Idarubicin. Antimetabolites, Antineoplastic. Antimetabolites. Molecular Mechanisms of Pharmacological Action. Antineoplastic ...
  https://clinicaltrials.gov/ct2/show/NCT01802333?cond=%22Acute+megakaryoblastic+leukemia%22&rank=1
*  Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High...
Drug Information available for: Cytarabine Idarubicin hydrochloride Idarubicin Clofarabine Genetic and Rare Diseases ... Patients receive idarubicin IV and cytarabine IV as in arm I. Patients also receive clofarabine IV by push injection over 10 ... Patients receive idarubicin IV over 5 minutes on days 1, 3, and 5, cytarabine IV continuously on days 1-10, and clofarabine IV ... Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High ...
  https://clinicaltrials.gov/ct2/show/study/NCT00838240?view=results
*  Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes - Tabular View - ClinicalTrials.gov
Drug: azacitidine and idarubicin azacitidine:100mg, 75mg/m²/d, during 7days every 28 days (D1-D7). Idarubicin: 5mg/ml, 5mg/m²/d ... Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes. This study has been completed. ... The first 10 patients will receive Idarubicin 5 mg/m2/d on day 8 of each cycle of Azacitidine 75 mg/m2/d CI during 7 days ( ... Progression or not to the next cohort of 10 patients : Idarubicin 10 mgm2/d on day 8 of each cycle of Azacitidine 75 mg/m2/d CI ...
  https://clinicaltrials.gov/ct2/show/record/NCT01305135
*  Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid...
Drug Information available for: Cytarabine Idarubicin hydrochloride Idarubicin Genetic and Rare Diseases Information Center ... This phase I/II trial is studying the side effects and best dose of tipifarnib when given with idarubicin and cytarabine and to ... Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid ... Drugs used in chemotherapy, such as idarubicin and cytarabine, work in different ways to stop cancer cells from dividing so ...
  https://clinicaltrials.gov/ct2/show/NCT00096122?cond=%22Acute+myeloblastic+leukemia+without+maturation%22&rank=10
*  Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS - Full Text View ...
Drug Information available for: Cytarabine Decitabine Idarubicin hydrochloride Idarubicin Genetic and Rare Diseases Information ... Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS. The safety and ... Experimental: Arm1: decitabine, idarubicin, cytarabine Patients receive decitabine IV over 1 hour on days -4 to 0, cytarabine ... Experimental: Arm2: decitabine, idarubicin, cytarabine Patients receive decitabine IV over 1 hour on days -9 to -5 and ...
  https://clinicaltrials.gov/ct2/show/NCT01607645?cond=%22Acute+myeloblastic+leukemia+without+maturation%22&rank=12
*  Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia - Full Text View - ClinicalTrials.gov
Drug Information available for: Cytarabine Idarubicin hydrochloride Idarubicin Lenalidomide Genetic and Rare Diseases ... Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia. This study has been completed. ... Drug: Lenalidomide Drug: Cytarabine Drug: Idarubicin Other: Pharmacological Study Other: Laboratory Biomarker Analysis Phase 1 ... This phase I trial studies the side effects and best dose of lenalidomide when given together with cytarabine and idarubicin in ...
  https://clinicaltrials.gov/ct2/show/NCT01132586?cond=%22Acute+myelocytic+leukemia%22&rank=4
*  Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma
The main objective of the trial is to assess the therapeutic activity of idarubicin as salvage treatment in patients with ... Salvage Therapy With Idarubicin in Immunocompetent Patients With Relapsed or Refractory Primary Central Nervous System ... Salvage Therapy With Idarubicin in Immunocompetent Patients With Relapsed or Refractory Primary Central Nervous System ...
  http://www.knowcancer.com/cancer-trials/NCT00210366/
*  Phase I/II Randomized Study of Clofarabine, Idarubicin, and Cytarabine (CIA) versus Fludarabine, Idarubicin, and Cytarabine ...
... idarubicin, and cytarabine, or the combination of fludarabine, idarubicin, and cytarabine can help control AML and MDS. The ... Phase I/II Randomized Study of Clofarabine, Idarubicin, and Cytarabine (CIA) versus Fludarabine, Idarubicin, and Cytarabine ( ... The goal of this clinical research study is to learn if the combination of clofarabine, idarubicin, and cytarabine, or the ... combination of fludarabine, idarubicin, and cytarabine can help control AML and MDS. The safety of these study drug ...
  https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2010-0788.html
*  Efficacy of, and toxicoses associated with, oral idarubicin administration in cats with neoplasia. - Semantic Scholar
Idarubicin (2 mg/cat/d for 3 days, q 3 wks) was used to treat 18 cats with lymphoma in which complete remission had been ... We concluded that orally administered idarubicin would be useful in the treatment of cats with lymphoma. ... Idarubicin, a new synthetic anthracycline analogue, was administered orally to 34 cats with spontaneous tumors. The maximum ... Idarubicin (2 mg/cat/d for 3 days, q 3 wks) was used to treat 18 cats with lymphoma in which complete remission had been ...
  https://www.semanticscholar.org/paper/Efficacy-of-and-toxicoses-associated-with-oral-ida-Moore-Ruslander/a50ee392b579dabd58fa269e22a819cccd38de89
*  Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia - Full...
Experimental: Arm I (idarubicin, cytarabine) Arm I: Patients receive idarubicin IV over 1 hour on days 1-3 and cytarabine IV ... Giving idarubicin and cytarabine with bevacizumab may kill more cancer cells. It is not yet know whether giving idarubicin ... Experimental: Arm II (idarubicin, cytarabine, bevacizumab) Patients receive idarubicin and cytarabine as in arm I. Patients ... Drug Information available for: Cytarabine Idarubicin hydrochloride Idarubicin Bevacizumab Genetic and Rare Diseases ...
  https://clinicaltrials.gov/ct2/show/NCT00096148?cond=%22Acute+monoblastic+leukemia%22&rank=4
*  S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia - Tabular View -...
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia. This study is ongoing ... pravastatin 1280 mg/d PO D 1-8 idarubicin 12 mg/m2/d IV D 4-6 AraC 1.5 g/m2/d contIV D 4-7 ... pravastatin 1280 mg/d PO D 1-6 idarubicin 12 mg/m2/d IV D 4-5 AraC 1.5 g/m2/d contIV D 4-5 ... S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML). ...
  https://clinicaltrials.gov/ct2/show/record/NCT00840177?show_locs=Y
*  Idarubicin | Encyclopedia.com
Source for information on Idarubicin: Gale Encyclopedia of Cancer dictionary. ... Idarubicin Definition Idarubicin is a medication that kills cancer cells. ... Idarubicin Gale Encyclopedia of Cancer COPYRIGHT 2002 The Gale Group Inc.. Idarubicin. Definition. Idarubicin is a medication ... Idarubicin may cause nausea and vomiting , baldness (alopecia ), and stomach problems. In addition, idarubicin may cause ...
  https://www.encyclopedia.com/medicine/encyclopedias-almanacs-transcripts-and-maps/idarubicin
*  Idarubicin - Medical Dictionary / Glossary | Medindia
Idarubicin' - An anticancer drug that belongs to the family of drugs called antitumor antibiotics. Also called 4- ... Medical Word - Idarubicin. Ans : An anticancer drug that belongs to the family of drugs called antitumor antibiotics. Also ... Idarubicin - Glossary. Written & Compiled by Medindia Content Team. Medically Reviewed by The Medindia Medical Review Team on ...
  https://www.medindia.net/glossary/idarubicin.htm
*  Idarubicin - Information and support - Macmillan Cancer Support
If you or someone close to you has been diagnosed with cancer, you're not alone. Find out what to expect, get information, practical advice and support, hear from experts and read about other people's experiences.
  https://www.macmillan.org.uk/information-and-support/lung-cancer/small-cell-lung-cancer/treating/chemotherapy/drugs-and-combination-regimens/individual-drugs/idarubicin.html
*  Definition of idarubicin hydrochloride - NCI Drug Dictionary - National Cancer Institute
Idarubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering ... The hydrochloride salt of the anthracycline antineoplastic antibiotic idarubicin. ... idarubicin hydrochloride The hydrochloride salt of the anthracycline antineoplastic antibiotic idarubicin. Idarubicin ... idarubicin HCl. US brand name:. Idamycin. Foreign brand name:. Zavedos. Zavedos. Abbreviation:. 4-DMDR. IDA. Code name:. IMI-30 ...
  https://www.cancer.gov/publications/dictionaries/cancer-drug/def/idarubicin-hydrochloride
*  Idarubicin - Slashdot User
by Idarubicin on Wednesday June 15, 2016 @11:05AM. (#52322633) Attached to: World Reacts To The Worst Mass Shooting In U.S. ... by Idarubicin on Monday June 13, 2016 @10:18AM. (#52307023) Attached to: World Reacts To The Worst Mass Shooting In U.S. ... by Idarubicin on Monday July 04, 2016 @12:51PM. (#52443641) Attached to: China Finishes Building Its Alien-Hunting Telescope ... by Idarubicin on Thursday July 07, 2016 @10:50AM. (#52463641) Attached to: Hyperloop One Says It Can Connect Helsinki To ...
  https://slashdot.org/users2.pl?page=1&uid=579475&view=userhomepage
*  Idarubicin cancer drug molecule - Stock Image F012/9146 - Science Photo Library
Idarubicin cancer drug molecule. Atoms are represented as spheres and are colour coded: hydrogen (white), carbon (grey), oxygen ... idarubicin, idarubicina, idarubicine, illustration, leukaemia, medication, medicinal, medicine, model, molecular, molecule, ... Caption: Idarubicin cancer drug molecule. Atoms are represented as spheres and are colour coded: hydrogen (white), carbon (grey ...
  http://www.sciencephoto.com/media/720401/view
*  Idarubicin cancer drug molecule - Stock Image F013/0442 - Science Photo Library
Idarubicin cancer drug molecule. Stylized skeletal formula (chemical structure). Atoms are shown as color-coded circles: ... idarubicin, idarubicina, idarubicine, illustration, leukaemia, model, molecular, molecule, myeloid, rubicin, structure, style, ... Caption: Idarubicin cancer drug molecule. Stylized skeletal formula (chemical structure). Atoms are shown as color-coded ...
  http://www.sciencephoto.com/media/724729/view
*  Idarubicin - Wikipedia
Idarubicin /ˌaɪdəˈruːbɪsɪn/ or 4-demethoxydaunorubicin is an anthracycline antileukemic drug. It inserts itself into DNA and ... Idarubicin bound to proteins in the PDB. ...
  https://en.wikipedia.org/wiki/Idarubicin
*  Treatment of relapsed acute myeloid leukemia with idarubicin and intermediate-dose cytarabine
... Harousseau JL, Reiffers J, ... idarubicin (IDARUB) at optimal dosage and cytarabine (ARA-C) at intermediate dosage. Thirty-five patients aged 23 to 78 years ( ...
  http://imsdd.meb.uni-bonn.de/cgi-bin/mycite?ExtRef=MEDL/89080803/PMID/2642539
*  Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006) - Full Text View - ClinicalTrials.gov
Drug Information available for: Cytarabine Idarubicin hydrochloride Idarubicin Sorafenib Sorafenib tosylate Genetic and Rare ... Experimental: Sorafenib + Idarubicin + Ara-C Sorafenib starting dose 400 mg orally for 7 days; Idarubicin 12 mg/m2 intravenous ... Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006). The safety and scientific validity of this study is the ... Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006), an Oral VEGF, RAF and FLT3 Inhibitor, in Patients With ...
  https://clinicaltrials.gov/ct2/show/NCT00542971
*  Idamycin PFS (idarubicin hydrochloride) dose, indications, adverse effects, interactions... from PDR.net
Idarubicin complexes with DNA by intercalating between DNA base pairs, causing the helix to change shape. Idarubicin has a ... Idarubicin is currently administered by slow IV injection (over 10-15 minutes). Idarubicin is converted to an active metabolite ... Both idarubicin and idarubicinol are 97% bound to plasma proteins. Idarubicin metabolism occurs primarily in the liver, however ... Idarubicin is a vesicant. Extravasations of idarubicin infusions should be avoided. Patients should be closely monitored during ...
  http://www.pdr.net/drug-summary/Idamycin-PFS-idarubicin-hydrochloride-1018